Invesco Biotechnology & Genome ETF
PBE
PBE
68 hedge funds and large institutions have $47.5M invested in Invesco Biotechnology & Genome ETF in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 30 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
60% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 30
Holders
68
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.08M | |
| 2 | +$738K | |
| 3 | +$602K | |
| 4 |
NDSI
Newman Dignan & Sheerar Inc
Providence,
Rhode Island
|
+$574K |
| 5 |
YIA
YHB Investment Advisors
West Hartford,
Connecticut
|
+$165K |
Top Sellers
| 1 | -$3.15M | |
| 2 | -$1.14M | |
| 3 | -$776K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$750K |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$708K |